Search

A new technology shows great promise for imaging and treating advanced forms of prostate cancer.

… Thursday, July 1, 2021 A transformation is coming for patients with prostate cancer , says Memorial Sloan Kettering medical oncologist Michael Morris . Researchers at MSK have helped pioneer major advances that will enable doctors to pinpoint the location of prostate cancer cells more precisely than

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

… Tuesday, May 14, 2013 Summary Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. This image shows melanocytes – cells that protect the skin from ultraviolet radiation – created in a Memorial Sloan Kettering laboratory using

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

… Thursday, July 10, 2025 Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer metastasis remains a stubborn threat. Metastasis is the name for cancer that has spread

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.

… Tuesday, September 8, 2015 Summary Memorial Sloan Kettering is pioneering the use of a noninvasive scanning technique that has the power to reveal whether a tumor is responding to a treatment within just a few days after a patient has started a regimen. This new platform from General Electric Healthcare

Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.

… Tuesday, October 9, 2018 Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols. Abbreviated breast MRI provides high diagnostic accuracy with

Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.

… Monday, June 30, 2025 Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute. Harrington Discovery Institute Scholar-Innovator Awards support the development

Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.

… Friday, January 11, 2019 Summary Immunotherapy drugs called checkpoint inhibitors can be very effective but don’t work for most people with prostate cancer . A small subset of men whose prostate tumors have a genetic abnormality called high microsatellite instability do respond to the drugs. Genetic

… Tuesday, August 21, 2012 Summary A team of researchers has made a breakthrough in solving a problem that has defied biologists for decades: How to compute a protein’s three-dimensional structure, or shape, based on genetic information. The discovery could accelerate diverse areas of biomedical discovery

This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.

… Tuesday, August 27, 2019 Summary The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found. Cells can die in several ways. One such method, discovered only within the past decade, is ferroptosis — literally

In a recently published paper MSK's Jun Mao explores the global challenges of cancer control and the current status of integrative oncology, offering recommendations to improve access to safe, effective, evidence-based, and culturally sensitive cancer care.

… Thursday, November 18, 2021 Cancer is a global health challenge that impacts countries large and small, affluent and impoverished. With population growth and aging, and success in the management of other acute and chronic diseases, the number of new cancer cases is expected to rise over the next two